Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

4 Stocks To Watch: FSLR, NKTR, RIOT, XOMA

Published 12/08/2017, 12:06 AM
Updated 07/09/2023, 06:31 AM

First Solar, Inc. (NASDAQ:FSLR) is extending up 3 days in a row off of a pullback low and support line, having gone from 56.00 to Thursday’s high at 68.70, closing up 5.19, or 8.2%, to 68.53, on 4.9 million shares traded. I’ve been telling you for months now that this stock is headed back to 73, which is the target. It has 6.9 days to cover .

Nektar Therapeutics (NASDAQ:NKTR) just won’t quit! It was up another 5.14, or 10%, to 54.83, on 2.9 million shares traded on Thursday. After pulling back a little bit, it held at the 48 1/2 area where support is, and went right back up to the highs at the close. If it accelerates, I will be looking for 61-2 short term. There’s 12.7 days to cover .

Riot Blockchain, Inc. (NASDAQ:RIOT) gained 90 cents, or 7%, to 14.60, on 5.7 million shares traded with a high of 16.11. I put a swing on this stock on Thursday, because after four waves up, the wedge that formed near the apex could pop. It started to move on Thursday. It didn’t close great. You can see the pullback late in the session. It also formed a big wedge intraday. I will be closely watching to see if they can take out 16 3/4 and 17 1/2. That is the key level for RIOT. If it takes that out, wave 5 can begin, first in the 24 range, and then 30.

XOMA Corporation (NASDAQ:XOMA) continues to look great. After the breakout and it formed a little pennant, it exploded and formed a rising channel. It was up 3.93, or 13.4%, to 33.28, on 376,862 shares traded with a high of 34.07 on Thursday. With a pickup in volume, it looks like it’s headed up to 38-40. That’s my near-term target.

On the long side, stocks included Collegium Pharmaceutical, Inc. (NASDAQ:COLL), Majesco Entertainment Company (NASDAQ:COOL), Depomed, Inc. (NASDAQ:DEPO), eGain Corporation (NASDAQ:EGAN), Foundation Medicine, Inc. (NASDAQ:FMI), First Solar, Inc. (NASDAQ:FSLR), Global Blood Therapeutics, Inc. (NASDAQ:GBT), Halozyme Therapeutics, Inc. (NASDAQ:HALO), At Home Group Inc. (NYSE:HOME), Immunomedics, Inc. (NASDAQ:IMMU), Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), Nektar Therapeutics (NASDAQ:NKTR), uniQure N.V. (NASDAQ:QURE), Riot Blockchain, Inc. (NASDAQ:RIOT), tact, Tailorktved Brands, Inc. (NYSE:TLRD), Viking Therapeutics, Inc. (NASDAQ:VKTX), Winnebago Industries, Inc. (NYSE:WGO), and XOMA Corporation (NASDAQ:XOMA).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.